ISOtretinoin (Systemic) and Osteoporosis
Result of checking the interaction of drug ISOtretinoin (Systemic) and disease Osteoporosis for safety when used together.
When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.
Consumer:Isotretinoin may have a negative effect on bone mineral density in some patients. Clinical trials have shown BMD declines in adolescents during a 20 week treatment. Therefore, physicians should use caution when prescribing isotretinoin in patients with a history of childhood osteoporosis, osteomalacia, or other disorders of bone metabolism.
Generic Name: isotretinoin
Brand Name: Absorica, Amnesteem, Claravis, Myorisan, Sotret, Zenatane, Accutane
Synonyms: Isotretinoin
ISOtretinoin (Systemic) - osteoporoza 
ISOtretinoin (Systemic) - osteoporose 
ISOtretinoin (Systemic) - osteoporosis 
ISOtretinoin (Systemic) - osteoporosis 
ISOtretinoin (Systemic) - osteoporosi 
ISOtretinoin (Systemic) - l'ostéoporose 
ISOtretinoin (Systemic) - Osteoporose 
ISOtretinoin (Systemic) - osteoporosis 
ISOtretinoin (Systemic) - остеопороз 
ISOtretinoin (Systemic) - osteoporoz 
ISOtretinoin (Systemic) - هشاشة العظام 
ISOtretinoin (Systemic) - 骨质疏松